LDN193189 (DM-3189) (GMP) isLDN193189(HY-12071) produced by using GMP guidelines.GMP small moleculesworks appropriately as an auxiliary reagent for cell therapy manufacture. LDN193189 is selectiveBMP type I receptorinhibitor^[1][2].

LDN193189 (GMP) (250 nM; 0-7 d) induces human pluripotent stem cells (hPSC) directly differentiates into midbrain dopamine neurons (mDA)^[1].
LDN193189 (GMP) (200 nM) induces the generation of glucose-responsive β cells from hPSCs in vitro^[2].

406.48

C₂₅H₂₂N₆

1062368-24-4

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.